Pharmacokinetics of ranitidine in critically ill infants

Dev Pharmacol Ther. 1989;12(1):7-12.

Abstract

The pharmacokinetic parameters of ranitidine were studied following administration of a single intravenous dose in 9 critically ill infants. Ranitidine disposition was best described by a biphasic elimination curve. For 8 patients, the mean values for T1/2, apparent volume of distribution, and total body clearance were 2.09 h, 1.61 l/kg, and 13.93 ml/min/kg, respectively. Based on simulated steady-state concentration profiles, a dose of 0.7 mg/kg administered intravenously every 6 h should maintain serum levels above 40 ng/ml for 4.7 h of the dosing interval with a wide degree of variability.

MeSH terms

  • Child, Preschool
  • Chloramphenicol / pharmacology
  • Drug Interactions
  • Female
  • Gastric Juice / analysis
  • Gastrointestinal Hemorrhage / drug therapy
  • Gastrointestinal Hemorrhage / metabolism
  • Heme / analysis
  • Humans
  • Infant
  • Infusions, Intravenous
  • Male
  • Metabolic Clearance Rate
  • Peptic Ulcer / prevention & control
  • Ranitidine / blood
  • Ranitidine / pharmacokinetics*
  • Ranitidine / pharmacology

Substances

  • Heme
  • Chloramphenicol
  • Ranitidine